Innovative Eyewear filings document a Nasdaq-listed smart eyewear issuer with common stock under LUCY and warrants under LUCYW. Recent Form 8-K reports cover results of operations, preliminary financial information, operational highlights, executive title and principal financial officer changes, and annual-meeting matters.
The company's regulatory disclosures also record stockholder voting outcomes, director elections, auditor ratification matters, quorum and adjournment mechanics, exhibit filings and Inline XBRL cover-page data. These filings frame the public-company record around governance, capital structure and event-driven disclosures for its smart eyewear business.
Innovative Eyewear (LUCY) reported preliminary, unaudited net sales for the third quarter ended September 30, 2026; management described them as the highest quarterly net sales in company history. The estimates remain subject to completion of quarter-end close procedures and review of interim financial statements, and actual results may differ materially.
During the quarter, the company opened three wholesale and international channels: a major U.S. big-box retailer, FYihealth Group in Canada, and Directed Electronics in Australia and New Zealand. The company plans to launch Lucyd Aero for holiday 2026 and expects to report full third-quarter results in mid-November 2026.
Innovative Eyewear, Inc. (LUCY) asks shareholders to elect Harrison Gross, Kristen McLaughlin, Louis Castro and Olivia C. Bartlett as directors, ratify Cherry Bekaert LLP for fiscal 2026, and approve a reverse stock split of 1-for-2 to 1-for-12. If approved, the board may decide whether and when to implement the split and select the ratio, provided it is effected within one year of shareholder approval. The 2026 annual meeting is scheduled for November 16, 2026. Holders of the 8,712,263 shares outstanding on September 21, 2026, are eligible to vote, subject to the control-share voting provisions.
The split would leave the 50,000,000 authorized common shares unchanged, and the company says it has no current plans to issue the potentially newly available shares. The board unanimously recommends voting FOR the director nominees and both other proposals.
Innovative Eyewear, Inc. is asking stockholders to approve an amendment authorizing a reverse split of its common stock at a ratio between 1-for-2 and 1-for-12. If approved, the board may decide whether and when to implement it and select the ratio in its sole discretion, provided it acts within one year of stockholder approval. As of September 21, 2026, 8,712,263 shares were outstanding; the company’s 50,000,000 authorized common shares would remain unchanged.
The November 16, 2026 virtual meeting also covers election of Harrison Gross, Kristen McLaughlin, Louis Castro and Olivia C. Bartlett, and ratification of Cherry Bekaert LLP as auditor for fiscal 2026. The board says the split is intended to raise the per-share price to meet the exchange’s continued-listing price requirement, but cannot assure a proportionate or lasting increase. The company says it has no current plans to issue the additional authorized shares.
Innovative Eyewear Inc (LUCY) received a Rule 144 notice indicating that officer Joaquin Abondano, through Raymond James & Associates, Inc., plans to sell 3,912 shares of common stock, with an aggregate market value of $3,376.14, on or about September 18, 2026. The notice states that 8,600,000 shares of this class were outstanding. It also lists an RSU grant of 14,800 common shares dated August 19, 2026, and discloses that Abondano sold 5,020 shares over the past three months for proceeds of $3,288.00.
Innovative Eyewear Inc (LUCY) is the issuer for a planned resale of its common stock under Rule 144 by Joaquin Abondano, identified as an officer. The notice covers a potential sale of up to 14,800 shares of common stock, originally received as an RSU grant, with Raymond James & Associates acting as broker.
The filing also reports that Abondano sold 5,020 shares of Innovative Eyewear common stock during the past three months for total proceeds of 3,288.00. The sales are to be made for cash on Nasdaq.
Innovative Eyewear Inc (LUCY) reported that Chief Financial Officer Gayle Oswald received two grants of 16,233 shares of common stock on April 2, 2026 and August 19, 2026 at $0.00 per share. On the same respective dates, she sold 7,574 shares at a $1.0725 average price and 7,959 shares at a $0.6745 average price in open market or private transactions. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to a trading plan, and it does not state her total holdings after these transactions.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski. He received grants of 20,900 shares of common stock on April 2, 2026 and August 19, 2026, each at no cost, and sold 6,692 shares on April 2 at $1.0581 per share and 6,935 shares on August 19 at a weighted-average price of $0.6911 per share in open-market or private transactions. Post-transaction holdings were not provided.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief Operating Officer Joaquin Abondano. On April 2 and August 19, 2026, he received two grants of 14,800 Common Shares each at $0.00 per share as awards. On the same dates, he sold 4,779 shares at $1.0501 per share and 5,020 shares at an average of $0.6765 per share in open-market or private transactions. The August 19 price is disclosed as a weighted average, with detailed trade breakdowns available on request. The filing states these transactions were not conducted under a Rule 10b5-1 trading plan.
Innovative Eyewear Inc (LUCY) reported that Chief Executive Officer and director Harrison R. Gross had both awards and sales of Common Stock. On April 2, 2026 and August 19, 2026, he received 24,600 shares on each date as a grant or award at $0.00 per share. On those same dates he sold shares in open market or private transactions, including 13,764 shares at an average price of $1.0658, 8,252 shares at an average price of $0.6916, and 5,722 shares at an average price of $0.705, with each price disclosed as a weighted average over multiple trades.
Innovative Eyewear Inc (LUCY) reported that Chief Technology Officer David Eric Cohen had a mix of stock grants and sales. On April 2 and August 19, 2026, he received 18,200 shares of common stock each time as grant/award acquisitions at $0.00 per share. Across April 2, April 9, July 6, and August 19, 2026, he sold a total of 15,769 shares of common stock in open-market or private transactions at per-share prices ranging from $1.0436–$1.17 and a weighted average price of $0.6802 for the August 19 sale.